Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Gastroenterol Hepatol ; 21(7): 335-8, 1998.
Artigo em Espanhol | MEDLINE | ID: mdl-9808897

RESUMO

Immunoproliferative disease of the small intestine (IPDSI) is rare and although it is more frequent in mediterranean countries it has more exceptionally been described in Western countries. IPDSI is characterized by diffuse infiltration of the small intestine mucose by lymphoblastic cells and over time may evolve to the development of lymphoma, generally of an immunoblastic nature. Another peculiarity of the disease is its association with heavy alpha chain disease (HACD). Several types of paraproteinemia may appear in the serum of patients, very seldom in the form of polymeric IgA, with the evolution of the cases reported in the literature not leading to the development of heavy chain disease or lymphoma. We herewith present an exceptional case of IPDSI in whom the association of HACD was discarded and in whom polymeric IgA paraproteinemia which evolved to the development of lymphoma was observed.


Assuntos
Imunoglobulina A/sangue , Neoplasias do Jejuno/imunologia , Linfoma/imunologia , Adulto , Humanos , Neoplasias do Jejuno/patologia , Linfoma/patologia , Masculino , Paraproteinemias/etiologia
2.
Rev Esp Enferm Apar Dig ; 76(6 Pt 2): 651-3, 1989 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-2633238

RESUMO

We have made a comparative cross study of 30 patients with chronic pancreatitis and steatorrhea. The aim of the study has been to compare the effectiveness of a new galenic form of pancreatin, in pellets, with the common galenic presentation, in tablets. In all the cases the cause of pancreatic failure was alcoholism. In both groups the treatment was administered during seven days, after a period of wash out. We evaluated steatorrhea and clinical symptoms, including the typical abdominal pain. (The doses administrated were 12 tablets/day or 9 pellets/day.) Statistically there was a significant decrease of steatorrhea p less than 0.01.


Assuntos
Pancreatina/administração & dosagem , Pancreatite/tratamento farmacológico , Dor Abdominal/tratamento farmacológico , Adulto , Doença Celíaca/etiologia , Doença Crônica , Formas de Dosagem , Avaliação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pancreatina/uso terapêutico , Pancreatite/complicações , Distribuição Aleatória , Comprimidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA